PHAT — Phathom Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $567.12m
- $934.14m
- $175.11m
Phathom Pharma rises as Craig-Hallum starts coverage with 'buy'
Brief: Carlyle Group Inc Reports 6.7% Passive Stake In Phathom Pharmaceuticals Inc As Of March 1 - SEC Filing
Brief: Phathom Pharmaceuticals Reports Q4 And Full Year 2022 Financial Results
Phathom Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Phathom Pharmaceuticals Posts Q4 Basic Shr Loss USD 1.33
Phathom Pharmaceuticals Inc expected to post a loss of $1.35 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Ralph Lauren, J.M. Smucker, Lions Gate
U.S. STOCKS ON THE MOVE-Silvergate Capital, PayPal, Spotify
Phathom Pharma tanks as FDA declines to approve inflammation drug
U.S. STOCKS ON THE MOVE-Cloudflare, Coursera, Corsair Gaming
Phathom Pharma falls as FDA declines to approve inflammation drug
Phathom Pharma slide as FDA declines approval of inflammation treatment
Brief: Phathom Pharmaceuticals Provides Regulatory Updates
Phathom extends losses as FDA seeks more data on acid blocker drug
Phathom falls as FDA seeks more data on acid blocker drug
Brief: Phathom Pharmaceuticals Provides Update On New Drug Application
Phathom Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: Phathom Pharmaceuticals Reports Q3 2022 Results
Phathom Pharmaceuticals Inc expected to post a loss of $1.32 a share - Earnings Preview